Ethical dilemmas contribute to ‘critical weaknesses’ in FDA postmarket oversight, experts say

Posted by & filed under Health Sciences.

Ethical challenges are central to persistent “critical weaknesses” in the national system for ensuring drug safety, according to a commentary by former Institute of Medicine (IOM) committee members published today in the New England Journal of Medicine.

Comments are closed.

Feedback

eSTEM Feedback

We appreciate any and all feedback about our site; praise, ideas, bug reports you name it!

e.g. Indifferent, Undecided, Unconcerned e.g.Kidding, Amused, Silly e.g. Happy, Confident, Grateful e.g. Sad, Dissapointed, Confused, Angry